MiPortal

InfectID™-BSI

A bloodstream infection (BSI) and sepsis pathogen identification blood test that requires no pre-culture.

E
Results in less than 3 hours laboratory time
E
Identifies 26 sepsis-associated bacteria and yeast species​
E
Direct testing from whole blood: only 0.4 mL required​
Get in touch below for more information. ​
Contact us

Targeted Pathogen Identification for Early Sepsis Management

Sepsis is a serious and complex healthcare challenge where timely intervention is crucial. Effective treatment relies on the accurate identification of pathogens. However, standard of care methods such as blood culture often fail to provide results quickly enough for prompt early treatment. This delay in identifying pathogens negatively affects patient outcomes and increases the risk of antimicrobial resistance (AMR) due to the extended use of broad-spectrum antibiotics.

InfectID™-BSI: Improving Standard of Care

InfectID™-BSI addresses the limitations of standard of care by using a direct molecular identification technique. While standard of care, including blood culture, remains necessary, InfectID™-BSI provides results within hours, enabling clinicians to make informed decisions for targeted therapy sooner. ​

InfectID™-BSI: Improving Bloodstream Infection and Sepsis Treatment

Less than 3 hours laboratory time to actionable results

By delivering clinically relevant information in less than 3 hours, InfectID™-BSI empowers clinicians to initiate targeted antimicrobial therapies promptly, improving patient outcomes.

Identifies the top 20 bacterial and 6 yeast pathogens

Identifies the pathogens responsible for 94% of sepsis cases, providing more comprehensive results than the current standard of care.

Direct from whole blood

Achieve rapid results without delays from enrichment or culture, streamlining the diagnostic process.

qPCR molecular detection

Detects the unique genetic fingerprint of pathogens, avoiding limitations often associated with traditional culture-based methods.

Uses the melt curve feature of qPCR

Assays are multiplexed without compromising high accuracy.

Minimally invasive sampling

Validated with just 0.4 mL of blood, InfectID™-BSI is particularly beneficial for patients who have difficulty providing large blood samples.

Key Benefits for Clinicians and Healthcare providers.

Addressing the Limitations of Current Methods

N

Enables Early Targeted Therapy

InfectID™-BSI delivers pathogen-specific information faster than blood culture, allowing clinicians to start more targeted treatments earlier.
N

Supports Antimicrobial Stewardship

By enabling more precise, early treatment, InfectID™-BSI reduces reliance on broad-spectrum antibiotics, helping to minimize AMR.
N

Enhanced Pathogen Detection

Standard of care often cannot culture fastidious pathogens or those that have been suppressed by prior antimicrobial therapy. InfectID™-BSI addresses these limitations by effectively identifying such pathogens, thereby closing critical gaps in diagnostic accuracy.
N

Broad Clinical Application


Designed for a wide range of clinical environments, InfectID™-BSI is ideal for use in intensive care units, emergency departments, and infectious disease clinics. Its ability to directly test whole blood with minimal sample size makes it especially suitable for neonatal and pediatric cases, as well as other patients where blood volume is difficult to provide.
N

Streamlined Workflow Integration


InfectID™-BSI’s rapid approach integrates seamlessly into existing laboratory workflows. Its compatibility with the QIAGEN® Rotor-Gene® Q platform and user-friendly software ensures that results are consistent, repeatable, and easily interpreted, providing actionable insights in time-sensitive situations.

Product Details

InfectID™-BSI Bacterial and Yeast Combined Detection Assay Kit for qPCR

Product number: MRB1300

Microbio’s Bloodstream Infection (BSI) qPCR kit (InfectID™-BSI) consists of in vitro nucleic acid amplification tests for the qualitative detection of sepsis-associated bacteria and yeast DNA directly from whole blood samples using qPCR.

Includes analysis and reporting software for consistent, repeatable results.

Microbio’s InfectID™-BSI assay is for professional use only. Results from Microbio’s InfectID™-BSI qPCR kit should be interpreted in conjunction with other clinical and laboratory findings.

The assay is validated to run on QIAGEN®’s Rotor-Gene® Q qPCR instrument.​

Related resources

Get in touch with our team to learn more.

Contact us